Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion type Assertion NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_head.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion evidence source_evidence_literature NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion SIO_000772 17962208 NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion wasDerivedFrom befree-20150227 NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.
- NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion wasGeneratedBy ECO_0000203 NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.